Exane Derivatives’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,706
Closed -$42.6K 1066
2021
Q1
$42.6K Buy
+1,706
New +$42.6K 0.01% 517